O
XERS icon

OppenheimerFunds’s Xeris Biopharma Holdings XERS Stock Holding History

OppenheimerFunds’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$10M Hold
1,000,000
– – 0.01% 670
2018
Q4 		$17M Hold
1,000,000
– – 0.02% 551
2018
Q3 		$17.6M Hold
1,000,000
– – 0.02% 614
2018
Q2 		$19M Buy
+1,000,000
New +$19.4M 0.02% 594

Other funds holding XERS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OppenheimerFunds's XERS Position: Q1 2019 in Review

OppenheimerFunds held its Xeris Biopharma Holdings (XERS) position steady in Q1 2019 at 1,000,000 shares worth $10M. The position accounts for 0.01% of the portfolio, ranked #670.

OppenheimerFunds first reported a position in XERS in Q2 2018 and has held it in 4 quarters since. The position peaked at $19M in Q2 2018. 49 funds tracked by Wall St. Rank hold XERS as of Q1 2019.

  • OppenheimerFunds held 1,000,000 shares of Xeris Biopharma Holdings worth $10M as of Q1 2019.
  • OppenheimerFunds left its Xeris Biopharma Holdings share count unchanged in Q1 2019.
  • Xeris Biopharma Holdings made up 0.01% of OppenheimerFunds's portfolio in Q1 2019, its #670 holding.
  • OppenheimerFunds first reported a position in Xeris Biopharma Holdings in Q2 2018 and has held it in 4 quarters since.
  • OppenheimerFunds's Xeris Biopharma Holdings position peaked at $19M in Q2 2018.
  • 49 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.